论文部分内容阅读
目的观察阿司匹林及低分子肝素联合奥扎格雷抗栓治疗急性冠脉综合征(ACS)疗效及安全性。方法 80例急性冠脉综合征患者随机分为治疗组及对照组各40例,治疗组使用阿司匹林及低分子肝素联合奥扎格雷,对照组使用阿司匹林及低分子肝素,2周后观察疗效及安全性。结果治疗组总有效率为95%,无效2例,出血2例,肝酶谱升高3例。对照组总有效率为80%,无效8例,出血2例,二组总有效率比较差异有统计学意义。结论阿司匹林及低分子肝素联合奥扎格雷抗栓治疗急性冠脉综合征安全有效。
Objective To observe the efficacy and safety of aspirin, low molecular weight heparin and ozagrel in the treatment of acute coronary syndrome (ACS). Methods Eighty patients with acute coronary syndrome were randomly divided into treatment group (40 cases) and control group (40 cases). In the treatment group, aspirin and LMWH plus ozagrel were used. In the control group, aspirin and LMWH were used. After 2 weeks, efficacy and safety Sex. Results The total effective rate was 95% in treatment group, 2 cases were ineffective, 2 cases had hemorrhage and 3 cases had elevated liver enzymes. The control group, the total effective rate was 80%, 8 cases were ineffective, bleeding in 2 cases, the total effective rate of the two groups was statistically significant difference. Conclusions Aspirin and low molecular weight heparin combined with Ozagrel antithrombotic therapy are safe and effective in the treatment of acute coronary syndrome.